Natural Product: NPC328649

Natural Product IDNPC328649
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Tyrocidine A
IUPAC Name 3-[(3R,6S,9S,12S,15S,18S,21S,24R,27S,30S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-propan-2-yl-1,4,7,10,13,16,19,22,25,28-decazabicyclo[28.3.0]tritriacontan-18-yl]propanamide
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL408504
PubChem CID 16129635
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000348] Peptides
            • [CHEMONTID:0001995] Cyclic peptides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey GSXRBRIWJGAPDU-BBVRJQLQSA-N
Standard InCHI InChI=1S/C66H87N13O13/c1-38(2)32-47-59(85)77-52(36-42-20-12-7-13-21-42)66(92)79-31-15-23-53(79)64(90)76-49(34-41-18-10-6-11-19-41)61(87)74-48(33-40-16-8-5-9-17-40)60(86)75-51(37-55(69)82)62(88)70-46(28-29-54(68)81)58(84)73-50(35-43-24-26-44(80)27-25-43)63(89)78-56(39(3)4)65(91)71-45(22-14-30-67)57(83)72-47/h5-13,16-21,24-27,38-39,45-53,56,80H,14-15,22-23,28-37,67H2,1-4H3,(H2,68,81)(H2,69,82)(H,70,88)(H,71,91)(H,72,83)(H,73,84)(H,74,87)(H,75,86)(H,76,90)(H,77,85)(H,78,89)/t45-,46-,47-,48+,49-,50-,51-,52+,53-,56-/m0/s1
SMILES NCCC[C@@H]1N=C(O)[C@@H](N=C(O)[C@H](Cc2ccc(cc2)O)N=C(O)[C@H](CCC(=N)O)N=C(O)[C@H](CC(=N)O)N=C(O)[C@H](N=C([C@@H](N=C([C@H]2N(C(=O)[C@H](N=C([C@@H](N=C1O)CC(C)C)O)Cc1ccccc1)CCC2)O)Cc1ccccc1)O)Cc1ccccc1)C(C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   1269.65 Volume:   1292.709
?
Van der Waals volume.
Dense:   0.982 LogP:   0.16
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.247
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -1.991
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   19.0 Rigid Bonds:   61.0
TPSA:   448.03
?
Topological Polar Surface Area.
H-Bond Acceptor:   26.0
H-Bond Donor:   16.0 Rings:   6.0
Heavy Atoms:   26.0

MedChem Properties

QED Drug-Likeness Score:   0.031 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   7.442 Fsp3:   0.455
MCE-18:   157.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.928 Fluc inhibitor:   0.143
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.007
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.895
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.004 Promiscuous compounds:   0.202

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.325 MDCK Permeability:   -5.131
Pgp-inhibitor:   0.908 Pgp-substrate:   1.0
PAMPA:   0.983
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.124
20% Bioavailability (F20%):   1.0 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.61
Plasma Protein Binding (PPB):   69.525% Volume Distribution (VD):   -0.369
Fu: 26.5%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.927 BCRP inhibitor:   0.025
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   1.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.119
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  -0.206 Half-life (T1/2):  3.001

ADMET: Toxicity

hERG Blockers:  0.0 hERG Blockers (10um):  0.0
Human Hepatotoxicity (H-HT):  1.0 Drug-induced Liver Injury (DILI):  1.0
AMES Toxicity:  0.0 Rat Oral Acute Toxicity:  0.966
Maximum Recommended Daily Dose:  0.954 Skin Sensitization:  1.0
Carcinogencity:  0.006 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.726
Drug-induced Neurotoxicity:  0.198 Ototoxicity:  1.0
Hematotoxicity:  0.307 Drug-induced Nephrotoxicity:  1.0
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.0
A549 Cytotoxicity:  0.0 Hek293 Cytotoxicity:  0.001
BCF:   0.295
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.327
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.761
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.705
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO23673 Brevibacillus brevis Species Paenibacillaceae Bacteria n.a. n.a. n.a. PMID[4320358]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT21750 Lipid Lipid bilayer n.a. Activity n.a. n.a. n.a. PMID[33991963]
NPT23991 Macromolecule Lipopolysaccharide (LPS) Bacteria Activity n.a. n.a. n.a. PMID[33991963]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT729 Organism Micrococcus luteus Micrococcus luteus IC50 = 22000.0 nM PMID[19586775]
NPT729 Organism Micrococcus luteus Micrococcus luteus ICmax = 70.0 uM PMID[19586775]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 8.3 ug.mL-1 PMID[14584933]
NPT79 Organism Bacillus subtilis Bacillus subtilis Ratio = 1.0 n.a. PMID[14584933]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 1.0 ug.mL-1 PMID[17547386]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 16.0 ug.mL-1 PMID[17728134]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 31.0 ug.mL-1 PMID[19281223]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 20.0 ug.mL-1 PMID[19281223]
NPT564 Organism Listeria monocytogenes Listeria monocytogenes Activity = 1.62 % PMID[19586775]
NPT564 Organism Listeria monocytogenes Listeria monocytogenes Activity = 59.0 % PMID[19586775]
NPT564 Organism Listeria monocytogenes Listeria monocytogenes IC50 = 13000.0 nM PMID[19586775]
NPT564 Organism Listeria monocytogenes Listeria monocytogenes ICmax = 25.0 uM PMID[19586775]
NPT564 Organism Listeria monocytogenes Listeria monocytogenes IC50 = 9900.0 nM PMID[19586775]
NPT564 Organism Listeria monocytogenes Listeria monocytogenes ICmax = 16.0 uM PMID[19586775]
NPT20 Organism Candida albicans Candida albicans MIC = 3125.0 nM PMID[29140694]
NPT20 Organism Candida albicans Candida albicans MIC = 780.0 nM PMID[29140694]
NPT20 Organism Candida albicans Candida albicans MIC = 390.0 nM PMID[29140694]
NPT23195 Subcellular Cell membrane Bacteria Activity n.a. n.a. n.a. PMID[33991963]
NPT19 Organism Escherichia coli Escherichia coli MIC = 8.0 ug.mL-1 PMID[17547386]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC = 1.0 ug.mL-1 PMID[17547386]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC = 1.0 ug.mL-1 PMID[17547386]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 32.0 ug.mL-1 PMID[17728134]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC = 16.0 ug.mL-1 PMID[17728134]
NPT19 Organism Escherichia coli Escherichia coli MIC > 128.0 ug.mL-1 PMID[17728134]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC = 16.0 ug.mL-1 PMID[17728134]
NPT19 Organism Escherichia coli Escherichia coli MIC = 25000.0 nM PMID[29140694]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC = 100000.0 nM PMID[29140694]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 1560.0 nM PMID[29140694]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 2500.0 nM PMID[33991963]
NPT19 Organism Escherichia coli Escherichia coli Activity n.a. n.a. n.a. PMID[33991963]
NPT20950 Cell line Erythrocyte n.a. HC50 = 14.0 uM PMID[33991963]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus Activity n.a. n.a. n.a. PMID[33991963]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC = 2500.0 nM PMID[33991963]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC = 80000.0 nM PMID[33991963]
NPT21742 Cell line L02 Homo sapiens Activity n.a. n.a. n.a. PMID[33991963]
NPT19 Organism Escherichia coli Escherichia coli MIC = 20000.0 nM PMID[33991963]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 20000.0 nM PMID[33991963]
NPT2 Others Unspecified n.a. Ratio = 2.0 ug ml-1 PMID[17547386]
NPT314 Organism Bacillus cereus Bacillus cereus MIC = 16.0 ug.mL-1 PMID[17728134]
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii MIC = 10000.0 nM PMID[33991963]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference
Listeria monocytogenes n.a. T1/2 = 0.5383 hr PMID[19586775]





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC328649 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7981 Intermediate Similarity NPC325976
0.7981 Intermediate Similarity NPC326363
0.6989 Remote Similarity NPC241794
0.6818 Remote Similarity NPC202198
0.6596 Remote Similarity NPC136797
0.6593 Remote Similarity NPC479072
0.6556 Remote Similarity NPC489829
0.6087 Remote Similarity NPC489557
0.6068 Remote Similarity NPC489555
0.6016 Remote Similarity NPC484875
0.5979 Remote Similarity NPC479074
0.5946 Remote Similarity NPC326349
0.5946 Remote Similarity NPC323336
0.5833 Remote Similarity NPC489822
0.5758 Remote Similarity NPC479070
0.5714 Remote Similarity NPC5194
0.566 Remote Similarity NPC58725
0.5644 Remote Similarity NPC141957
0.5591 Remote Similarity NPC224315
0.5545 Remote Similarity NPC261934
0.5545 Remote Similarity NPC489825
0.5545 Remote Similarity NPC489826
0.5537 Remote Similarity NPC489549
0.5532 Remote Similarity NPC485876
0.551 Remote Similarity NPC489556
0.5484 Remote Similarity NPC242482
0.5472 Remote Similarity NPC489828
0.5455 Remote Similarity NPC485116
0.5417 Remote Similarity NPC479068
0.5405 Remote Similarity NPC238945
0.5405 Remote Similarity NPC296968
0.5312 Remote Similarity NPC255447
0.5299 Remote Similarity NPC61004
0.5275 Remote Similarity NPC200589
0.5263 Remote Similarity NPC489593
0.5238 Remote Similarity NPC242159
0.5204 Remote Similarity NPC485094
0.5145 Remote Similarity NPC485114
0.5143 Remote Similarity NPC479069
0.5135 Remote Similarity NPC31385
0.5133 Remote Similarity NPC489823
0.513 Remote Similarity NPC487230
0.5109 Remote Similarity NPC484874
0.5102 Remote Similarity NPC200964
0.51 Remote Similarity NPC489592
0.5098 Remote Similarity NPC56685
0.5086 Remote Similarity NPC487229
0.5057 Remote Similarity NPC486124
0.5048 Remote Similarity NPC262166
0.5047 Remote Similarity NPC302597
0.5041 Remote Similarity NPC484348

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC328649 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5357 Remote Similarity NPD8405 Pre-clinical

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data